We’ve been using Super Beta Prostate Advanced for a few months now and have noticed a significant reduction in urges to urinate, especially during the night. We also appreciate that it includes ...
Super Beta Prostate Advanced is a great option to consider. We’ve been using Super Beta Prostate Advanced for a few weeks now, and we’ve noticed a significant reduction in our urges to urinate ...
Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...
For those who need to brush up on their anatomy, the prostate is a walnut-size gland that can be found about two inches inside the rectum and is chock-full of super-sensitive nerve endings.
Some people with advanced castrate-resistant prostate cancer now have a new option: PSMA lutetium-177, also known as lutetium Lu 177 vipivotide tetraxetan, a radiopharmaceutical.
A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought. A new study led by researchers at the UCLA Health ...
Advanced imaging reveals hidden metastases in high-risk prostate cancer cases, offering new insights for better diagnosis and treatment strategies. Many cases of high-risk nonmetastatic hormone ...
A breakthrough in prostate cancer treatment has seen a drug shrink tumours in advanced disease. The experimental medicine, also being trialled for ovarian disease, could help men who are no longer ...
While hormone therapies have extended the lives of lots of men with advanced prostate cancer, drug resistance is inevitable. We need to tackle the problem from a new angle Dr Adam Sharp ...
An innovative new drug being trialled to tackle certain cancers could also benefit patients with advanced prostate cancer whose treatment has stopped working, according to scientists. Experts ...
The study, published in JAMA Network Open, found that nearly half of high-risk prostate cancer patients previously classified as nonmetastatic by conventional imaging actually have metastatic ...